Pfizer Launching 'Generic Viagra' Pills At Lower Price On Dec. 11
The new pill would be available for $32.50, half that of the existing $65 per-pill price.
Corporations With Offshore Billions Sponsor 'Tax Prom'
Congressional staffers, lobbyists and think tank employees will get together for an annual D.C. tradition imbued with extra significance this year: the Tax Foundation’s gala, brought to you by 61 corporations interested in seeing their tax bills reduced.
Shareholders Can’t Force Pharmaceutical Company To Prove Drugs Aren’t Used For Executions
New York’s $192 billion pension fund put forward a shareholder resolution that would’ve forced Cardinal Health to demonstrate that its products weren’t being used in lethal injections. Regulators stood in the way.
Cure For Cancer: Novartis Drug Zykadia Beats Chemotherapy In Lung Cancer Patients
Zykadia more than doubled the median progression-free survival rate for patients suffering from anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
-
Pfizer Pneumonia Vaccine: Company Cuts Price For Humanitarian Emergency Cases
-
Pfizer (PFE) Announces Medivation Acquisition Worth $14 Billion
-
Dow Jones Industrial Average Rallies As Warren Buffett Reports $1 Billion Apple Inc. (AAPL) Stake, Oil Prices Surge
-
Pfizer Inc. (PFE) To Acquire Anacor Pharmaceuticals Inc. (ANAC) For $5.2B
-
'TrumpRx': President Unveils New Drug Price-Cutting Website As Pfizer Agrees To Slash Costs By 50%
More news
No More Execution Drugs: Pfizer Cuts Off Last US Market Source Of Drugs To Kill Convicts
But the move might not hamper the death penalty. Some states allow hangings if lethal-injection drugs aren’t available.
Pfizer Inc. (PFE) Tops Earnings Estimates With 20% Jump In Q1 Revenue
The American pharmaceutical giant’s first-quarter revenue, boosted by its cancer drug sales and acquisition of Hospira, came in at $13 billion.
In Frenzy Of Pharmaceutical Mergers And Acquisitions, Tensions And Unanswered Questions
Pharmaceutical companies announced deals worth $40 billion this week, but not everyone is convinced they’re good for business.
Sanofi Makes Unsolicited $9.3 Billion Bid For Medivation (MDVN)
The French pharmaceutical multinational made an offer for the U.S. drugmaker in an effort to expand its cancer-treatment business.
Panama Papers: Corporations Shifted A Half-Trillion Dollars To Offshore Tax Havens In 2012
In some small countries, the profits reported by American corporations are larger than the entire gross domestic product.
Is The UK A Tax Haven? London, British Islands Questioned After Panama Papers Leak
Parliament should probe the nation's tax practices and consider direct rule of territories that serve as tax havens, Labour leader Jeremy Corbyn says.
Obama Claims Trophy With Collapse Of Pfizer-Allergan Merger, But Inversions Debate Continues
The Treasury’s new rules on inversion-type transactions torpedoed the pharmaceutical deal, but a tough debate about corporate tax reform remains.
Pfizer (PFE) Cancels Allergan (AGN) Merger Deal Amid US Tax Inversion Curbs
The $160 billion deal, announced last year, was canceled Wednesday after the U.S. Department of Treasury passed a new law to curb tax inversion deals.
Dow Jones Industrial Average Sinks As Financial Sector, Disney Shares Weigh, Outlook For Interest Rates Remains Cloudy
Shares of the media giant were a major drag on the Dow on Tuesday after the company said a veteran executive will step down.
US Issues New Rules To Curb Corporate Tax Inversion Deals
Under the new rules, there will be a three-year limit on foreign companies bulking up on U.S. assets to avoid ownership requirements for a later inversions deal.
Pfizer-Allergan Merger: Tax Inversion Deal Would Help US Pharma Giant Dodge $35B In Taxes, Report Says
According to Americans for Tax Fairness, the deal would allow the U.S. pharma giant to "permanently dodge" taxes owed on about $148 billion in overseas profits.
Did The Fed Raise Rates Too Soon? The Dollar Is Strong, But American Consumers Are Coming Back
The most important economic variable of 2016 might be whether American consumers are strong enough to withstand the cold winds blowing in from abroad.
Is There A Vaccine For The Zika Virus? Pfizer, Johnson & Johnson, Merck Are Exploring Developing One
Developing a vaccine against the mosquito-borne virus could take years, researchers have said.
Pfizer Revenue Rises As Pneumonia Vaccine Sales Jump
The New York-based pharmaceutical company reported a better-than-expected 7 percent rise in quarterly revenue Tuesday.
Johnson & Johnson Cutting About 3,000 Jobs In Medical Devices Division
The healthcare conglomerate said Tuesday the restructuring would affect its orthopedics, surgery and cardiovascular businesses.
Pfizer Hikes US Prices For Over 100 Drugs
The company raised prices, by as much as 20 percent for some drugs, on Jan. 1.
Global M&A Activity In 2015 Worth $4.28 Trillion, Highest Ever
The past year saw deals worth nearly $4.3 trillion — significantly above the previous peak, before the financial crisis, according to a Thursday report.
GlaxoSmithKline To Buy Bristol-Myers Squibb's HIV Assets For $1.46B
The deals, which include an upfront payment of $350 million, will help the British drugmaker compete with its American rival Gilead Sciences.
AstraZeneca-Acerta Talks: British Pharma Giant Confirms Bid For Cancer Drug Firm
The British drugmaker has shown interest in Acerta's anti cancer treatments, particularly an experimental drug called Acalabrutinib.
Merger And Acquisition Activity Hits Record High in 2015: Report
Global M&A activity rose as companies looked for tax havens and took advantage of cheap interest rates, the Wall Street Journal reported, citing a research report.
Asian Shares Mixed After US Closes Lower
Japan stocks are little changed after a holiday while Australian shares fell, dragged down by falling metal prices.
After Pfizer-Allergan Deal, Global Mergers And Acquisitions Hit Record $3.8 Trillion
The total value of mergers and acquisitions has surpassed the previous record set in 2007, with more than $3.8 trillion in global transactions.
Pages
- Prev
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- Next
- Promoted in Unemployment
- 1
- 2
- 3
- 4
- 5
Editor's pick
-
Democrats Might Expand Medicare if They Win the House. Lower Eligibility Age for Coverage Is on the Table.
-
Zcash Just Crossed $1,000 for the First Time in a Decade. One Short Seller Lost $18.5 Million.
-
The Jobs Report Surprised To The Upside. Stocks Dropped.
-
The U.S. Is Seeking To Cut Iran Off From The Global Financial System. It Is Targeting A Turkish Bank To Do So.
-
Former Labor Secretary Misused Government Resources and Drank at Work. Employees Describe 'Toxic' Atmosphere In Report.
-
Bitcoin Is Heading For Its Third Straight Winning Week. A Strong Jobs Report Complicated The Rally.
